These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Ifenprodil discriminates subtypes of the N-methyl-D-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors. Williams K Mol Pharmacol; 1993 Oct; 44(4):851-9. PubMed ID: 7901753 [TBL] [Abstract][Full Text] [Related]
7. Soluble HIV-1 infected macrophage secretory products mediate blockade of long-term potentiation: a mechanism for cognitive dysfunction in HIV-1-associated dementia. Xiong H; Zeng YC; Zheng J; Thylin M; Gendelman HE J Neurovirol; 1999 Oct; 5(5):519-28. PubMed ID: 10568889 [TBL] [Abstract][Full Text] [Related]
8. Antagonist properties of eliprodil and other NMDA receptor antagonists at rat NR1A/NR2A and NR1A/NR2B receptors expressed in Xenopus oocytes. Avenet P; Léonardon J; Besnard F; Graham D; Depoortere H; Scatton B Neurosci Lett; 1997 Feb; 223(2):133-6. PubMed ID: 9089691 [TBL] [Abstract][Full Text] [Related]
11. Antagonist properties of the stereoisomers of ifenprodil at NR1A/NR2A and NR1A/NR2B subtypes of the NMDA receptor expressed in Xenopus oocytes. Avenet P; Léonardon J; Besnard F; Graham D; Frost J; Depoortere H; Langer SZ; Scatton B Eur J Pharmacol; 1996 Jan; 296(2):209-13. PubMed ID: 8838458 [TBL] [Abstract][Full Text] [Related]
12. Influence of a threonine residue in the S2 ligand binding domain in determining agonist potency and deactivation rate of recombinant NR1a/NR2D NMDA receptors. Chen PE; Johnston AR; Mok MH; Schoepfer R; Wyllie DJ J Physiol; 2004 Jul; 558(Pt 1):45-58. PubMed ID: 15107472 [TBL] [Abstract][Full Text] [Related]
13. Effects of memantine on recombinant rat NMDA receptors expressed in HEK 293 cells. Bresink I; Benke TA; Collett VJ; Seal AJ; Parsons CG; Henley JM; Collingridge GL Br J Pharmacol; 1996 Sep; 119(2):195-204. PubMed ID: 8886398 [TBL] [Abstract][Full Text] [Related]
14. Subunit-specific potentiation of recombinant N-methyl-D-aspartate receptors by histamine. Williams K Mol Pharmacol; 1994 Sep; 46(3):531-41. PubMed ID: 7935335 [TBL] [Abstract][Full Text] [Related]
16. Unraveling the mechanisms of neurotoxicity in HIV type 1-associated dementia: inhibition of neuronal synaptic transmission by macrophage secretory products. Xiong H; Zheng J; Thylin M; Gendelman HE AIDS Res Hum Retroviruses; 1999 Jan; 15(1):57-63. PubMed ID: 10024053 [TBL] [Abstract][Full Text] [Related]
17. Glutamate is a mediator of neurotoxicity in secretions of activated HIV-1-infected macrophages. Jiang ZG; Piggee C; Heyes MP; Murphy C; Quearry B; Bauer M; Zheng J; Gendelman HE; Markey SP J Neuroimmunol; 2001 Jul; 117(1-2):97-107. PubMed ID: 11431009 [TBL] [Abstract][Full Text] [Related]
18. Pharmacological properties of recombinant human N-methyl-D-aspartate receptors comprising NR1a/NR2A and NR1a/NR2B subunit assemblies expressed in permanently transfected mouse fibroblast cells. Priestley T; Laughton P; Myers J; Le Bourdellés B; Kerby J; Whiting PJ Mol Pharmacol; 1995 Nov; 48(5):841-8. PubMed ID: 7476914 [TBL] [Abstract][Full Text] [Related]
19. Modulation of 45Ca2+ influx into cells stably expressing recombinant human NMDA receptors by ligands acting at distinct recognition sites. Grimwood S; Gilbert E; Ragan CI; Hutson PH J Neurochem; 1996 Jun; 66(6):2589-95. PubMed ID: 8632186 [TBL] [Abstract][Full Text] [Related]
20. Mechanisms influencing stimulatory effects of spermine at recombinant N-methyl-D-aspartate receptors. Williams K Mol Pharmacol; 1994 Jul; 46(1):161-8. PubMed ID: 8058050 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]